EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 3.0

Survival Outcomes in Patients with Advanced Hepatocellular Carcinoma Based on Pretreatment Serum Lactate Dehydrogenase Level and Albumin-Bilirubin Grade: A Single-Center, Retrospective, Non-Randomized Cohort Study

Rong Yu, Huaxi Fan, Guishu Wu, Jing Zhang, Xiaolong Liu, Xiangyu Deng, Mingyue Rao, Jianwen Zhang

Journal of Hepatocellular Carcinoma · 2026-10 · Volume 13 · 1-16

DOI: 10.2147/jhc.s634409 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Hepatocellular Carcinoma, 2026-10. Verfasst von Rong Yu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

albumin-bilirubin gradehepatocellular carcinomaimmune checkpoint inhibitorslactate dehydrogenaseprognosisradiotherapy

Autor:innen und Institutionen

  • Department of Oncology, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, People's Republic of China.
  • Department of Oncology, the First People's Hospital of Liangshan Yi Autonomous Prefecture, Liangshan, Sichuan, 615000, People's Republic of China.
  • Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou, Sichuan, 646000, People's Republic of China.
  • Academician (Expert) Workstation of Sichuan Province, Luzhou, Sichuan, 646000, People's Republic of China.

Zitieren

APA

Yu, R., Fan, H., Wu, G., Zhang, J., Liu, X., Deng, X., Rao, M., & Zhang, J. (2026). Survival Outcomes in Patients with Advanced Hepatocellular Carcinoma Based on Pretreatment Serum Lactate Dehydrogenase Level and Albumin-Bilirubin Grade: A Single-Center, Retrospective, Non-Randomized Cohort Study. Journal of Hepatocellular Carcinoma, Volume 13, 1-16. https://doi.org/10.2147/jhc.s634409

Vancouver

Yu R, Fan H, Wu G, Zhang J, Liu X, Deng X, et al. Survival Outcomes in Patients with Advanced Hepatocellular Carcinoma Based on Pretreatment Serum Lactate Dehydrogenase Level and Albumin-Bilirubin Grade: A Single-Center, Retrospective, Non-Randomized Cohort Study. Journal of Hepatocellular Carcinoma. 2026;Volume 13:1-16. doi:10.2147/jhc.s634409

BibTeX
@article{Yu2026,
  author = {Yu, Rong and Fan, Huaxi and Wu, Guishu and Zhang, Jing and Liu, Xiaolong and Deng, Xiangyu and Rao, Mingyue and Zhang, Jianwen},
  title = {Survival Outcomes in Patients with Advanced Hepatocellular Carcinoma Based on Pretreatment Serum Lactate Dehydrogenase Level and Albumin-Bilirubin Grade: A Single-Center, Retrospective, Non-Randomized Cohort Study},
  journal = {Journal of Hepatocellular Carcinoma},
  year = {2026},
  volume = {Volume 13},
  pages = {1--16},
  doi = {10.2147/jhc.s634409}
}
Kostenlos starten →